Close Menu

NEW YORK (360Dx) – The broader markets weighed down the share prices of almost every diagnostic firm in December as the 360Dx Index slid nearly 12 percent compared to November. 

Of the 28 companies in the index, only one, Veracyte (+3 percent), saw a month-over-month improvement in its stock price last month. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.